MarketInOut Stock Screener Log In | Sign Up

Harrow Inc

IEX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/10/2026 15:59
Harrow Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization1,122.57 mln
Float31.80 mln
Earnings Date11/09/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

63.00
Transformational upside

Relative Strength

79 / 100
Strongly outperforming

Debt / Equity

19.79
Extremely leveraged

Pre-Tax Margin

-12%
Loss-making

Business Description

Harrow Inc. is a Nashville-based eye care company focused on developing and selling prescription medications that treat a wide range of eye conditions across the United States. The company sells both branded products and compounded medications through its two main business divisions, offering treatments for conditions such as infections, inflammation, macular degeneration, diabetic eye disease, and dry eye. Originally founded in 1998 under the name Harrow Health Inc., the company rebranded to Harrow Inc. in 2023.

Key Fundamentals

EPS-0.99
ROE-96.43
RPS8.15
ROIC2.08
ROA-9.55
Interest Cover0.25
EBITDA, mln10.80
EV / EBITDA131
EV / EBIT-135
Revenue, mln276
EV / Revenue5.13

Quote Details

Last 30.33
Change 2.95 (10.77%)
Open 33.00
Volume 1,887,582
Turnover 57,250,360
Average Volume 550,913

Financial Ratios

Pre-Tax Profit Margin-12
Leverage Ratio15.36
Current Ratio2.24
Price / Book78.32
Price / Free Cash Flow274
Debt / Equity19.79
Price / Sales4.38

Financial Strength

Altman Z-Score1.81
Piotroski F-Score 5 / 9
Beneish M-Score-2.68
1-Year Target Price63.00
Short Ratio11.49
Short % of Float22.19

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.27% 88 / 100   
1 Month 4.19% 72 / 100   
2 Months -23.04% 18 / 100   
6 Months 4.48% 67 / 100   
1 Year -10.61% 34 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog